These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8938676)

  • 1. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
    Singh A; Tejani A
    Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression enhances atherogenicity of lipid profile after transplantation.
    Quaschning T; Mainka T; Nauck M; Rump LC; Wanner C; Krämer-Guth A
    Kidney Int Suppl; 1999 Jul; 71():S235-7. PubMed ID: 10412786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
    Martínez Castelao A; Ramos R; Serón D; Gil-Vernet S; Fiol C; Gómez-Gerique N; Yzaguirre MT; Hurtado I; Sabaté I; Alsina J; Grinyó JM
    Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
    J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
    Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients.
    Wheeler DC; Morgan R; Thomas DM; Seed M; Rees A; Moore RH
    Transpl Int; 1996; 9(3):221-6. PubMed ID: 8723190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential analysis of the lipid profile of children post-renal transplantation.
    Singh A; Tejani C; Benfield M; Tejani A
    Pediatr Transplant; 1998 Aug; 2(3):216-23. PubMed ID: 10084746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
    Chin C; Rosenthal D; Bernstein D
    Pediatr Transplant; 2000 Aug; 4(3):193-9. PubMed ID: 10933319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
    Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.
    Spinelli GA; Felipe CR; Park SI; Mandia-Sampaio EL; Tedesco-Silva H; Medina-Pestana JO
    Transplant Proc; 2011 Dec; 43(10):3730-7. PubMed ID: 22172836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
    Aguilar-Salinas CA; Díaz-Polanco A; Quintana E; Macias N; Arellano A; Ramírez E; Ordóñez ML; Velásquez-Alva C; Gómez Pérez FJ; Alberú J; Correa-Rotter R
    Am J Kidney Dis; 2002 Jul; 40(1):169-77. PubMed ID: 12087575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
    Hilbrands LB; Demacker PN; Hoitsma AJ; Stalenhoef AF; Koene RA
    J Am Soc Nephrol; 1995 Jun; 5(12):2073-81. PubMed ID: 7579056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients.
    Azrolan N; Brown CD; Thomas L; Hayek T; Zhao ZH; Roberts KG; Scheiner C; Friedman EA
    Arterioscler Thromb; 1994 Sep; 14(9):1393-8. PubMed ID: 8068598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.
    Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M
    Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.